Search

Your search keyword '"Lavu, Sravanthi"' showing total 22 results
Start Over Author "Lavu, Sravanthi"
22 results on '"Lavu, Sravanthi"'

1. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype

Author

Senum, Sarah R., Li, Ying (Sabrina) M., Benson, Katherine A., Joli, Giancarlo, Olinger, Eric, Lavu, Sravanthi, Madsen, Charles D., Gregory, Adriana V., Neatu, Ruxandra, Kline, Timothy L., Audrézet, Marie-Pierre, Outeda, Patricia, Nau, Cherie B., Meijer, Esther, Ali, Hamad, Steinman, Theodore I., Mrug, Michal, Phelan, Paul J., Watnick, Terry J., Peters, Dorien J.M., Ong, Albert C.M., Conlon, Peter J., Perrone, Ronald D., Cornec-Le Gall, Emilie, Hogan, Marie C., Torres, Vicente E., Sayer, John A., and Harris, Peter C.

Published
2022
Full Text
View/download PDF

3. Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease

Author

Hopp, Katharina, Cornec-Le Gall, Emilie, Senum, Sarah R., te Paske, Iris B.A.W., Raj, Sonam, Lavu, Sravanthi, Baheti, Saurabh, Edwards, Marie E., Madsen, Charles D., Heyer, Christina M., Ong, Albert C.M., Bae, Kyongtae T., Fatica, Richard, Steinman, Theodore I., Chapman, Arlene B., Gitomer, Berenice, Perrone, Ronald D., Rahbari-Oskoui, Frederic F., Torres, Vicente E., and Harris, Peter C.

Published
2020
Full Text
View/download PDF

7. Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma

Author

Miyabe, Katsuyuki, primary, Chandrasekhara, Vinay, additional, Wongjarupong, Nicha, additional, Chen, Jun, additional, Yang, Lu, additional, Johnson, Stephen, additional, Chia, Nicholas, additional, Walther-Antonio, Marina, additional, Yao, Janet, additional, Harrington, Sean, additional, Nordyke, Cynthia, additional, Eaton, John, additional, Gossard, Andrea, additional, Oli, Sharad, additional, Ali, Hamdi, additional, Lavu, Sravanthi, additional, Giama, Nasra, additional, Hassan, Fatima, additional, Ali, Hawa, additional, Enders, Felicity, additional, Ilyas, Sumera, additional, Gores, Gregory, additional, Topazian, Mark, additional, Kashyap, Purna, additional, and Roberts, Lewis, additional

Published
2022
Full Text
View/download PDF

8. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma

Author

Lavu, Sravanthi, primary, Therneau, Terry M., additional, Harmsen, William S., additional, Mara, Kristin C., additional, Wongjarupong, Nicha, additional, Hassan, Mohamed, additional, Ali, Hamdi A., additional, Antwi, Samuel, additional, Giama, Nasra H., additional, Miyabe, Katsuyuki, additional, and Roberts, Lewis R., additional

Published
2020
Full Text
View/download PDF

9. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD

Author

Lavu, Sravanthi, primary, Vaughan, Lisa E., additional, Senum, Sarah R., additional, Kline, Timothy L., additional, Chapman, Arlene B., additional, Perrone, Ronald D., additional, Mrug, Michal, additional, Braun, William E., additional, Steinman, Theodore I., additional, Rahbari-Oskoui, Frederic F., additional, Brosnahan, Godela M., additional, Bae, Kyongtae T., additional, Landsittel, Douglas, additional, Chebib, Fouad T., additional, Yu, Alan S.L., additional, Torres, Vicente E., additional, and Harris, Peter C., additional

Published
2020
Full Text
View/download PDF

10. 45 The Role of the Biliary and Gut Microbiome in the Progression of Cholangiocarcinoma and Primary Sclerosing Cholangitis

Author

Nicholas Chia, Hawa M. Ali, Andrea A. Gossard, Gregory J. Gores, Vinay Chandrasekhara, Marina Walther-Antonio, Purna C. Kashyap, Lewis R. Roberts, Sharad Oli, Stephen Johnson, Felicity Enders, Sumera Rizvi, Janet Yao, Jun Chen, Miyabe Katsuyuki, Nicha Wongjarupong, Hamdi A. Ali, Mark Topazian, Lavu Sravanthi, Fatima Hassan, Sean C. Harrington, and Nasra H. Giama

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, medicine.disease, business, Gut microbiome, Primary sclerosing cholangitis
Published
2019
Full Text
View/download PDF

11. GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

Author

Yang, Ju Dong, primary, Addissie, Benyam D., additional, Mara, Kristin C., additional, Harmsen, William S., additional, Dai, Jianliang, additional, Zhang, Ning, additional, Wongjarupong, Nicha, additional, Ali, Hawa M., additional, Ali, Hamdi A., additional, Hassan, Fatima A., additional, Lavu, Sravanthi, additional, Cvinar, Jessica L., additional, Giama, Nasra H., additional, Moser, Catherine D., additional, Miyabe, Katsuyuki, additional, Allotey, Loretta K., additional, Algeciras-Schimnich, Alicia, additional, Theobald, J. Paul, additional, Ward, Melissa M., additional, Nguyen, Mindie H., additional, Befeler, Alex S., additional, Reddy, K. Rajender, additional, Schwartz, Myron, additional, Harnois, Denise M., additional, Yamada, Hiroyuki, additional, Srivastava, Sudhir, additional, Rinaudo, Jo Ann, additional, Gores, Gregory J., additional, Feng, Ziding, additional, Marrero, Jorge A., additional, and Roberts, Lewis R., additional

Published
2019
Full Text
View/download PDF

13. JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2 V617F mutated disease

Author

Tefferi, Ayalew, primary, Lavu, Sravanthi, additional, Mudireddy, Mythri, additional, Lasho, Terra L., additional, Finke, Christy M., additional, Gangat, Naseema, additional, Pardanani, Animesh, additional, Hanson, Curtis A., additional, Mannarelli, Carmela, additional, Guglielmelli, Paola, additional, and Vannucchi, Alessandro M., additional

Published
2018
Full Text
View/download PDF

14. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases

Author

Lavu, Sravanthi, primary, Szuber, Natasha, additional, Mudireddy, Mythri, additional, Yogarajah, Meera, additional, Gangat, Naseema, additional, Pardanani, Animesh, additional, Hanson, Curtis A., additional, Ketterling, Rhett P., additional, Ashrani, Aneel A., additional, Kamath, Patrick S., additional, and Tefferi, Ayalew, additional

Published
2017
Full Text
View/download PDF

15. Detection of Cholangiocarcinoma by Assay of Methylated DNA Markers in Plasma

Author

Yang, Ju Dong, primary, Yab, Tracy C., additional, Taylor, William R., additional, Foote, Patrick H., additional, Ali, Hamdi A., additional, Lavu, Sravanthi, additional, Simonson, Julie A., additional, Burger, Kelli N., additional, Mahoney, Douglas W., additional, Slettedahl, Seth W., additional, Gores, Gregory J., additional, Roberts, Lewis R., additional, Ahlquist, David A., additional, and Kisiel, John B., additional

Published
2017
Full Text
View/download PDF

16. GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.

Author

Ju Dong Yang, Addissie, Benyam D., Mara, Kristin C., Harmsen, William S., Jianliang Dai, Ning Zhang, Wongjarupong, Nicha, Ali, Hawa M., Ali, Hamdi A., Hassan, Fatima A., Lavu, Sravanthi, Cvinar, Jessica L., Giama, Nasra H., Moser, Catherine D., Miyabe, Katsuyuki, Allotey, Loretta K., Algeciras-Schimnich, Alicia, Theobald, J. Paul, Ward, Melissa M., and Nguyen, Mindie H.

Abstract

Background: The GALAD score is a serum biomarker-based model that predicts the probability of having hepatocellular carcinoma (HCC) in patients with chronic liver disease. We aimed to assess the performance of the GALAD score in comparison with liver ultrasound for detection of HCC. Methods: A single-center cohort of 111 HCC patients and 180 controls with cirrhosis or chronic hepatitis B and a multicenter cohort of 233 early HCC and 412 cirrhosis patients from the Early Detection Research Network (EDRN) phase II HCC Study were analyzed. Results: The area under the ROC curve (AUC) of the GALAD score for HCC detection was 0.95 [95% confidence interval (CI), 0.93-97], which was higher than the AUC of ultrasound (0.82, P <0.01). At a cutoff of -0.76, the GALAD score had a sensitivity of 91% and a specificity of 85% for HCC detection. The AUC of the GALAD score for early-stage HCC detection remained high at 0.92 (95% CI, 0.88-0.96; cutoff -1.18, sensitivity 92%, specificity 79%). The AUC of the GALAD score for HCC detection was 0.88 (95% CI, 0.85-0.91) in the EDRN cohort. The combination of GALAD and ultrasound (GALADUS score) further improved the performance of the GALAD score in the single-center cohort, achieving an AUC of 0.98 (95% CI, 0.96-0.99; cutoff -0.18, sensitivity 95%, specificity 91%). Conclusions: The performance of the GALAD score was superior to ultrasound for HCC detection. The GALADUS score further enhanced the performance of the GALAD score. Impact: The GALAD score was validated in the United States. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

22. JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease.

Author

Tefferi A, Lavu S, Mudireddy M, Lasho TL, Finke CM, Gangat N, Pardanani A, Hanson CA, Mannarelli C, Guglielmelli P, and Vannucchi AM

Subjects
Aged, Blood Cell Count, Disease Progression, Exons genetics, Female, Follow-Up Studies, Hemoglobins analysis, Humans, Kaplan-Meier Estimate, Leukemia, Myeloid, Acute epidemiology, Male, Middle Aged, Mutation, Missense, Polycythemia Vera blood, Polycythemia Vera mortality, Primary Myelofibrosis epidemiology, Splenomegaly epidemiology, Splenomegaly etiology, Thrombosis epidemiology, Thrombosis etiology, Janus Kinase 2 genetics, Polycythemia Vera genetics
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results